These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 27498367)
1. Potent ameliorating effect of Hypoxia-inducible factor 1α (HIF-1α) antagonist YC-1 on combined allergic rhinitis and asthma syndrome (CARAS) in Rats. Wang X; Liu C; Wu L; Zhu S Eur J Pharmacol; 2016 Oct; 788():343-350. PubMed ID: 27498367 [TBL] [Abstract][Full Text] [Related]
2. Benzaldehyde suppresses murine allergic asthma and rhinitis. Jang TY; Park CS; Kim KS; Heo MJ; Kim YH Int Immunopharmacol; 2014 Oct; 22(2):444-50. PubMed ID: 25107441 [TBL] [Abstract][Full Text] [Related]
3. The role of hypoxia-inducible factor 1α in allergic rhinitis. Mo JH; Kim JH; Lim DJ; Kim EH Am J Rhinol Allergy; 2014; 28(2):e100-6. PubMed ID: 24717944 [TBL] [Abstract][Full Text] [Related]
4. Glucosamine has an antiallergic effect in mice with allergic asthma and rhinitis. Jung AY; Heo MJ; Kim YH Int Forum Allergy Rhinol; 2017 Aug; 7(8):763-769. PubMed ID: 28558148 [TBL] [Abstract][Full Text] [Related]
5. [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats]. Shen WD; Zhang W; Xu QH; Liu PF Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):749-754. PubMed ID: 27938560 [No Abstract] [Full Text] [Related]
6. Warifteine and methylwarifteine inhibited the type 2 immune response on combined allergic rhinitis and asthma syndrome (CARAS) experimental model through NF-кB pathway. Cavalcanti RFP; Gadelha FAAF; de Jesus TG; Cavalcante-Silva LHA; Paiva Ferreira LKD; Paiva Ferreira LAM; Vieira GC; Piuvezam MR Int Immunopharmacol; 2020 Aug; 85():106616. PubMed ID: 32450529 [TBL] [Abstract][Full Text] [Related]
7. 4-Carvomenthenol ameliorates the murine combined allergic rhinitis and asthma syndrome by inhibiting IL-13 and mucus production via p38MAPK/NF-κB signaling pathway axis. Bezerra Barros GC; Paiva Ferreira LKD; Ferreira LAMP; Mozzini Monteiro T; Alves AF; Pereira RA; Piuvezam MR Int Immunopharmacol; 2020 Nov; 88():106938. PubMed ID: 33182052 [TBL] [Abstract][Full Text] [Related]
8. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome. Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of baicalin on allergic response in ovalbumin-induced allergic rhinitis guinea pigs and lipopolysaccharide-stimulated human mast cells. Zhou YJ; Wang H; Sui HH; Li L; Zhou CL; Huang JJ Inflamm Res; 2016 Aug; 65(8):603-12. PubMed ID: 27043920 [TBL] [Abstract][Full Text] [Related]
10. Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function. Crotty Alexander LE; Akong-Moore K; Feldstein S; Johansson P; Nguyen A; McEachern EK; Nicatia S; Cowburn AS; Olson J; Cho JY; Isaacs H; Johnson RS; Broide DH; Nizet V J Mol Med (Berl); 2013 May; 91(5):637-44. PubMed ID: 23250618 [TBL] [Abstract][Full Text] [Related]
11. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades. Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479 [TBL] [Abstract][Full Text] [Related]
12. [Effect of RORC inhibitor on HIF-1α and VEGF in nasal mucosa of allergic rhinitis of mice]. Wei PC; Tong L; Li R Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Oct; 53(10):751-756. PubMed ID: 30347534 [No Abstract] [Full Text] [Related]
13. TLR4 antagonist ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing inflammatory monocytes infiltration in mice model. Tang H; Li T; Han X; Sun J Int Immunopharmacol; 2019 Aug; 73():254-260. PubMed ID: 31121415 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1α inhibition modulates airway hyperresponsiveness and nitric oxide levels in a BALB/c mouse model of asthma. Dewitz C; McEachern E; Shin S; Akong K; Nagle DG; Broide DH; Akuthota P; Crotty Alexander LE Clin Immunol; 2017 Mar; 176():94-99. PubMed ID: 28093362 [TBL] [Abstract][Full Text] [Related]
15. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816 [TBL] [Abstract][Full Text] [Related]
16. Treatment of allergic rhinitis with CpG oligodeoxynucleotides alleviates the lower airway outcomes of combined allergic rhinitis and asthma syndrome via a mechanism that possibly involves in TSLP. Li HT; Chen ZG; Liu H; Ye J; Zou XL; Wang YH; Yang HL; Meng P; Zhang TT Exp Lung Res; 2016 Aug; 42(6):322-33. PubMed ID: 27541375 [TBL] [Abstract][Full Text] [Related]
18. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818 [TBL] [Abstract][Full Text] [Related]
19. CCR3 gene knockout in bone marrow cells ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing airway inflammatory cell infiltration and Th2 cytokines expression in mice model. Dai M; Zhu X; Yu J; Yuan J; Zhu Y; Bao Y; Yong X Int Immunopharmacol; 2022 Mar; 104():108509. PubMed ID: 34998035 [TBL] [Abstract][Full Text] [Related]
20. The effect of 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) on cell viability under hypoxia. Tsui L; Fong TH; Wang IJ Mol Vis; 2013; 19():2260-73. PubMed ID: 24265542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]